Laseroptek
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Laseroptek makes laser-based devices used in cosmetic skin treatments and in treating medical conditions such as vitiligo (a skin pigmentation disorder).
Its products are used by clinics and medical professionals, and the company ships to customers across multiple countries. Listed on KOSDAQ, South Korea's tech-focused small-cap exchange, it has expanded from cosmetic lasers into therapeutic medical devices, and its product portfolio now spans both categories.
Summary is AI-generated and may contain errors · figures from DART filings
The company developed what it describes as the world's first solid-state UVB laser device using titanium-sapphire crystal technology for vitiligo treatment, entering a market previously dominated by imported excimer devices.
Laseroptek in five facts
What does Laseroptek do?
Laseroptek makes laser-based devices used in cosmetic skin treatments and in treating medical conditions such as vitiligo (a skin pigmentation disorder).
Where is Laseroptek listed and in which sector?
Laseroptek (Korean name: 레이저옵텍) trades under KRX code 199550 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Medical Devices.
How large is Laseroptek?
Its market capitalisation was US$33.3M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Laseroptek's latest annual revenue and operating profit?
For fiscal year 2025, Laseroptek reported revenue of US$19.4M, an operating loss of US$9.1M and a net loss of US$8.1M, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was down 22.2% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Report on securities held by executives/major shareholdersSep 10
- Report on large shareholdings (5% rule) (standard)Sep 10
- [Amended] Material event report (rights offering)
Laseroptek updated the terms of a new share issuance to raise US$6.92M, about 21.3% of its market value.
Capital raise · Apr 16 · 4 versions - Subscription results of rights offering or equity-linked bonds (voluntary) (rights offering with public offering of forfeited shares)Capital raise · Apr 10
- Rights offering: final issue price set (rights offering with public offering of forfeited shares)Capital raise · Apr 6
- Ex-rights (rights offering)Capital raise · Feb 9
- Rights offering: round 1 issue price setCapital raise · Feb 9
- Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Laseroptek reported consolidated results for FY2025: revenue of US$17.5M (−22.2% year on year), an operating loss of US$7.85M and a net loss of US$6.01M.
Earnings · Feb 6